US4503151A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Recombinant cDNA construction method and hybrid nucleotides useful in cloning
Assignee: RESEARCH Corp TECHNOLOGIES Inc A NONPROFIT CORP OF DE
•
Filing: 1982-11-22
•
Granted: 1985-03-05
•
Expires: 2002-11-22
Abstract
Abstract Compounds useful as complementary DNA (cDNA) include deoxyribonucleotides and at least one ribonucleotide. They may be depicted by the general formula: <IMAGE> wherein (dN)a and (dN)c represent series of deoxyribonucleotides and (rN)b represents a series of ribonucleotides; wherein a, b, and c are the number of nucleotides in the series, with the proviso that b is >/=1, a is >/=35, and c is >/=10; wherein the series of deoxyribonucleotides (dN)a includes a series of deoxyribonucleotides which is substantially complementary to the series of deoxyribonucleotides (dN)c and the dashed line represents noncovalent bonding between the complementary deoxyribonucleotide series; and wherein the solid line represents a covalent phosphodiester bond. These compounds may be prepared from messenger RNA (mRNA) containing the genetic information necessary for cellular production of desired products such as polypeptides. After appropriate modification, they may be combined with DNA from a suitable cloning vehicle such as a plasmid and the resulting combined DNA used to transform bacterial cells. The transformed bacterial cells may then be grown and harvested; and the desired product or products recovered.
Inventors
- 👤 Gary V. Paddock
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 05:28
CPC Classifications
C; C07; C07H; C07H21/00; C12; C12N; C12N15/00
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
166 words
A compound having the general formula: ##STR10## wherein (dN) a and (dN) c represent series of deoxyribonucleotides, (dN') d , (dN') e , (dN") f , and (dN") g represent series of identical deoxyribonucleotides, the series (dN') d being complementary to the series (dN") f and the series (dN') e being complementary to the series (dN") g and (rN) b represents a series of ribonucleotides; wherein a, b, c, d, e, f, and g are numbers of nucleotides in the series, provided that b is ≧1, a is ≧35, and c, d, e, f, and g are ≧10; wherein the series of deoxyribonucleotides (dN) a includes a series of deoxyribonucleotides which is substantially complementary to the series of deoxyribonucleotides (dN) c ; wherein the xxx-lines represent double-stranded DNA derived from a cloning vehicle, wherein the dotted lines may be either no bonds or covalent bonds; wherein the dashed lines represent non-covalent bonding between the complementary deoxyribonucleotide series; and wherein the solid lines represent covalent phosphodiester bonds.
Claim 2
Dependent Claim
166 words
A compound having the general formula: ##STR10## wherein (dN) a and (dN) c represent series of deoxyribonucleotides, (dN') d , (dN') e , (dN") f , and (dN") g represent series of identical deoxyribonucleotides, the series (dN') d being complementary to the series (dN") f and the series (dN') e being complementary to the series (dN") g and (rN) b represents a series of ribonucleotides; wherein a, b, c, d, e, f, and g are numbers of nucleotides in the series, provided that b is ≧1, a is ≧35, and c, d, e, f, and g are ≧10; wherein the series of deoxyribonucleotides (dN) a includes a series of deoxyribonucleotides which is substantially complementary to the series of deoxyribonucleotides (dN) c ; wherein the xxx-lines represent double-stranded DNA derived from a cloning vehicle, wherein the dotted lines may be either no bonds or covalent bonds; wherein the dashed lines represent non-covalent bonding between the complementary deoxyribonucleotide series; and wherein the solid lines represent covalent phosphodiester bonds.
Claim 3
Dependent Claim
14 words
A compound in accordance with claim 1 wherein the cloning vehicle is a plasmid.
Claim 4
Dependent Claim
12 words
A compound in accordance with claim 2 wherein the plasmid is pBR322.
Claim 5
Dependent Claim
22 words
A method of transforming a bacterial or eucaryotic cell which comprises transforming the cell with a compound in accordance with claim 1.
Claim 6
Dependent Claim
16 words
A method in accordance with claim 4 wherein the bacterial cell is an Escherichia coli cell.
Claim 7
Dependent Claim
15 words
A transformed cell which comprises a cell containing a compound in accordance with claim 1.
Claim 8
Independent Claim
199 words
A method of producing a desired product which comprises cloning and growing cells transformed with a compound having the general formula: ##STR11## wherein (dN) a and (dN) c represent series of deoxyribonucleotides, (dn') d , (dN') e , (dN") f , and (dN") g represent series of identical deoxyribonucleotides, the series (dN') d being complementary to the series (dN") f and the series (dN') e being complementary to the series (dN") g and (rN) b represents a series of ribonucleotides; wherein a, b, c, d, e, f, and g are numbers of nucleotides in the series, provided that b is ≧1, a is ≧35, and c, d, e, f, and g are ≧10; wherein the series of deoxyribonucleotides (dN) a includes a series of deoxyribonucleotides which is substantially complementary to the series of deoxyribonucleotides (dN) c ; wherein the xxx-lines represent double-stranded DNA derived from a cloning vehicle, wherein the dotted lines may be either no bonds or covalent bonds; wherein the dashed lines represent non-covalent bonding between the complementary deoxyribonucleotide series; and wherein the solid lines represent covalent phosphodiester bonds, which contains the information necessary for the production of said desired product, and recovering the resulting desired product.
Claim 9
Independent Claim
199 words
A method of producing a desired product which comprises cloning and growing cells transformed with a compound having the general formula: ##STR11## wherein (dN) a and (dN) c represent series of deoxyribonucleotides, (dn') d , (dN') e , (dN") f , and (dN") g represent series of identical deoxyribonucleotides, the series (dN') d being complementary to the series (dN") f and the series (dN') e being complementary to the series (dN") g and (rN) b represents a series of ribonucleotides; wherein a, b, c, d, e, f, and g are numbers of nucleotides in the series, provided that b is ≧1, a is ≧35, and c, d, e, f, and g are ≧10; wherein the series of deoxyribonucleotides (dN) a includes a series of deoxyribonucleotides which is substantially complementary to the series of deoxyribonucleotides (dN) c ; wherein the xxx-lines represent double-stranded DNA derived from a cloning vehicle, wherein the dotted lines may be either no bonds or covalent bonds; wherein the dashed lines represent non-covalent bonding between the complementary deoxyribonucleotide series; and wherein the solid lines represent covalent phosphodiester bonds, which contains the information necessary for the production of said desired product, and recovering the resulting desired product.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-03-04 | 1988-09-03 | 1989-03-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-03-04 | 1992-09-03 | 1993-03-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-03-04 | 1996-09-03 | 1997-03-05 | $7700.00 | Window Closed / Lapsed |